u 69593 has been researched along with nalbuphine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell, GI; Breder, CD; Kong, H; Raynor, K; Reisine, T; Takeda, J; Yasuda, K | 1 |
Frey, HH | 1 |
DeYoung, MB; Lewis, JW; Sumpter, TL; Traynor, JR; Vivian, JA; Woods, JH | 1 |
French, AM; Smith, MA | 1 |
Craft, RM; McNiel, DM | 1 |
Bogen, O; Ferrari, LF; Gear, RW; Green, PG; Levine, JD | 1 |
6 other study(ies) available for u 69593 and nalbuphine
Article | Year |
---|---|
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brain Chemistry; Cloning, Molecular; In Situ Hybridization; Mice; Molecular Sequence Data; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Somatostatin; RNA, Messenger; Sequence Homology, Amino Acid; Substrate Specificity; Tissue Distribution | 1993 |
Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzeneacetamides; Benzodiazepines; Benzomorphans; Electroshock; Fentanyl; Male; Mice; Morphinans; Morphine; Nalbuphine; Naloxone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Seizures | 1988 |
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Azocines; Benzeneacetamides; Butorphanol; Cinnamates; Conditioning, Operant; Discrimination Learning; Diuresis; Dose-Response Relationship, Drug; Ethylketocyclazocine; Female; Injections, Intramuscular; Macaca mulatta; Male; Morphine Derivatives; Nalbuphine; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, kappa | 1999 |
Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Age Factors; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Animals; Benzeneacetamides; Butorphanol; Cold Temperature; Dose-Response Relationship, Drug; Drug Synergism; Male; Nalbuphine; Pain; Pain Measurement; Pyrrolidines; Rats; Rats, Inbred F344; Reaction Time; Receptors, Opioid, kappa | 2002 |
Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Topics: Animals; Benzeneacetamides; Butorphanol; Diuresis; Diuretics; Dose-Response Relationship, Drug; Female; Male; Nalbuphine; Naltrexone; Narcotic Antagonists; Pentazocine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Urination | 2003 |
NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.
Topics: Analgesics; Analysis of Variance; Animals; Benzeneacetamides; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Nalbuphine; Naloxone; Narcotic Antagonists; Nociceptin; Opioid Peptides; Pain Measurement; Pain Threshold; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sex Differentiation | 2014 |